Progression from hypertrophic to dilated cardiomyopathy in mice that express a mutant myosin transgene

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 280, Issue 1 49-1, 2001, Pages

  Freeman, Kalev ^a   Colon Rivera, Cynthia ^a   Olsson, M Charlotte ^a   Moore, Russell L ^a   Weinberger, Howard D ^b   Grupp, Ingrid L ^c   Vikstrom, Karen L ^d   Iaccarino, Guido ^e   Koch, Walter J ^e   Leinwand, Leslie A ^a  

^a UNIVERSITY OF COLORADO   (United States)

^b UNIVERSITY OF COLORADO   (United States)

^c UNIVERSITY OF CINCINNATI MEDICAL CENTER   (United States)

^d SUNY UPSTATE MEDICAL UNIVERSITY   (United States)

^e DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Cardiac decompensation; Exercise intolerance; Myosin heavy chain; Adrenergic receptor kinase 1

Indexed keywords

ACTIN BINDING PROTEIN; BETA ADRENERGIC RECEPTOR KINASE; G PROTEIN COUPLED RECEPTOR; ISOPRENALINE; MYOSIN; PHOSPHOTRANSFERASE; UNCLASSIFIED DRUG;

ADRENERGIC SYSTEM; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DISEASE COURSE; ENZYME ACTIVITY; EXERCISE TOLERANCE; GENE DELETION; GENE EXPRESSION; GENE MUTATION; HEART CONTRACTION; HEART DILATATION; HEART FAILURE; HEART FUNCTION; HEART MUSCLE RELAXATION; HEMODYNAMICS; HISTOPATHOLOGY; HYPERTROPHIC CARDIOMYOPATHY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; TRANSGENE;

EID: 0034999263     PISSN: 03636135     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpheart.2001.280.1.h151     Document Type: Article

References (46)

1. MLP-deficient mice exhibit a disruption of cardiac cytoarchitectural organization, dilated cardiomyopathy, and heart failure
2. Familial hypertrophic cardiomyopathy: From mutations to functional defects
3. Decreased catecholamine sensitivity and beta-adrenergic-receptor density in failing human hearts
4. Pressure- and volume-induced left ventricular hypertrophies are associated with distinct myocyte phenotypes and differential induction of peptide growth factor mRNAs
5. Sex-associated differences in left ventricular function in aortic stenosis of the elderly
6. Myocardial beta adrenoceptors and left ventricular function in hypertrophic cardiomyopathy
7. Comparison of clinical findings in idiopathic dilated cardiomyopathy in women versus men
8. Medical therapy can improve the biological properties of the chronically failing heart. A new era in the treatment of heart failure
9. A treadmill exercise regimen for identifying cardiovascular phenotypes in transgenic mice
10. A mouse model of familial hypertrophic cardiomyopathy
11. The pathogenesis of familial hypertrophic cardiomyopathy: Early and evolving effects from an alpha-cardiac myosin heavy chain missense mutation
12. Inheritance of hypertrophic cardiomyopathy: A cross sectional and M mode echocardiographic study of 50 families
13. The isolated work-performing mouse heart preparation. Comparison and quantification of cardiac performance in transgenic and wild-type mice
14. Comparison of normal, hypodynamic, and hyperdynamic mouse hearts using isolated work-performing heart preparations
15. Diastolic dysfunction in hypertrophic cardiomyopathy. Effect on active force generation during systole
16. Turning off the signal: Desensitization of beta-adrenergic receptor function
17. Exercise and beta-blocker therapy in alpha-myosin heavy chain mutant mice with hypertrophic cardiomyopathy
18. Coexistence of sudden cardiac death and end-stage heart failure in familial hypertrophic cardiomyopathy
19. Myocardial G protein-coupled receptor kinases: Implications for heart failure therapy
20. Reciprocal in vivo regulation of myocardial G protein-coupled receptor kinase expression by beta-adrenergic receptor stimulation and blockade
21. Adrenergic control of the force-frequency and relaxation-frequency relations in patients with hypertrophic cardiomyopathy
22. Ablation of the murine alpha myosin heavy chain gene leads to dosage effects and functional deficits in the heart
23. Cardiac function in mice overexpressing the beta-adrenergic receptor kinase or a beta ARK inhibitor
24. 1-adrenergic inotropic responsiveness in rats with mild hypertension
25. G protein-coupled receptor kinases
26. The frequency of familial dilated cardiomyopathy in a series of patients with idiopathic dilated cardiomyopathy
27. Enhanced myocardial function in transgenic mice overexpressing the beta 2-adrenergic receptor
28. Alpha-cardiac actin is a novel disease gene in familial hypertrophic cardiomyopathy
29. A calcineurin-dependent transcriptional pathway for cardiac hypertrophy
30. Molecular basis of cardiac performance. Plasticity of the myocardium generated through protein isoform switches
31. Cardiac myosin heavy chain mRNA expression and myocardial function in the mouse heart
32. Actin mutations in dilated cardiomyopathy, a heritable form of heart failure
33. Cardiomyopathy and myocardial failure
34. Both hypertrophic and dilated cardiomyopathies are caused by mutation of the same gene, delta-sarcoglycan, in hamster: An animal model of disrupted dystrophin-associated glycoprotein complex
35. Myocardial presynaptic and postsynaptic autonomic dysfunction in hypertrophic cardiomyopathy
36. Alpha-skeletal muscle actin mRNAs accumulate in hypertrophied adult rat hearts
37. Natural history of hypertrophic cardiomyopathy
38. Occurrence and significance of progressive left ventricular wall thinning and relative cavity dilatation in hypertrophic cardiomyopathy
39. The management of hypertrophic cardiomyopathy
40. Heterologous expression of a cardiomyopathic myosin that is defective in its actin interaction
41. Cardiac troponin T mutations result in allele-specific phenotypes in a mouse model for hypertrophic cardiomyopathy
42. Progression to left ventricular dilatation in patients with hypertrophic obstructive cardiomyopathy
43. Expression of beta-arrestins and beta-adrenergic receptor kinases in the failing human heart
44. Hypertrophy, pathology, and molecular markers of cardiac pathogenesis
45. Mice expressing mutant myosin heavy chains are a model for familial hypertrophic cardiomyopathy
46. Preserved Frank-Starling mechanism in human end stage heart failure